Image

Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects

Study on pritelivir tablets for acyclovir-resistant herpes in immunocompromised patients.

Recruiting
16 years and older
All
Phase 3

This study is testing a new medicine called Pritelivir for people who are immunocompromised, meaning their immune system is weaker. They have infections from the Herpes Simplex Virus (HSV) that don't get better with a common medicine called Acyclovir. The study compares Pritelivir with other treatments like Foscarnet or Cidofovir. Participants take Pritelivir once a day after a starting dose. The study aims to see if Pritelivir works better and is safe for patients.

Key Points:

  • The study could last up to 28 days, with a possible extension to 42 days.
  • Participants must be immunocompromised and have HSV resistant to Acyclovir.
  • Participants need to agree to use birth control and have regular checkups.

The study is divided into different parts, each with specific requirements. Participants must be at least 16 years old (18 in some countries) and cannot have certain other health problems. Pregnant or breastfeeding women cannot join. The goal is to see if all herpes sores heal in the study period.

Study details
    HSV Infection

NCT03073967

AiCuris Anti-infective Cures AG

15 March 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.